Shanghai Best-Link Bioscience
PrivateLast Round
Series C
May 15, 2026
Total Funding Raised
$153.39M
Company Overview
Shanghai Best-Link Bioscience is a biotechnology company that develops innovative drugs for tumor therapy using its proprietary nano-conjugate drug platform (NMPDC®).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shanghai Best-Link Bioscience Comparables
Compare Shanghai Best-Link Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tianjin Conjustar Biotechnology Co., Ltd. | 84% | |
| RS Research | 83% | |
| Cybrexa Therapeutics | 81% |
Shanghai Best-Link Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | May 15, 2026 | ||||
| Series B | Jan 28, 2026 | ||||
| Series B | Jan 28, 2024 | ||||
| Series A | Apr 8, 2023 | ||||
| Angel | Jun 10, 2021 |
Shanghai Best-Link Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Tianjin TEDA Science and Technology Investment Co., Ltd. | Series B |
| Lapam Capital | Series B, Series A |
| Tigeryeah Capital | Series B, Series A |
| CAS Star | Series B |
| Yonghua Capital | Series B |
| Hyfinity Investments | Series A |
Shanghai Best-Link Bioscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Shanghai Best-Link Bioscience's valuation, stock price, and market status.
Is Shanghai Best-Link Bioscience a public or private company?
Shanghai Best-Link Bioscience is a private company.
What is the current stock price of Shanghai Best-Link Bioscience?
Shanghai Best-Link Bioscience is a private company with no public stock price. No recent secondary market data is available.
How much is Shanghai Best-Link Bioscience worth (valuation)?
Valuation information for Shanghai Best-Link Bioscience is not publicly available.
Can I buy Shanghai Best-Link Bioscience stock?
Shanghai Best-Link Bioscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Shanghai Best-Link Bioscience's last funding round?
Shanghai Best-Link Bioscience's most recent funding round was Series B on January 28, 2024.
Who are the main investors in Shanghai Best-Link Bioscience?
Key investors in Shanghai Best-Link Bioscience include Lapam Capital, Yonghua Capital.
Will Shanghai Best-Link Bioscience IPO soon?
No public IPO plans have been announced for Shanghai Best-Link Bioscience.
How can I track Shanghai Best-Link Bioscience secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Shanghai Best-Link Bioscience's secondary market activity and sign up for updates.